Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.

Sakamoto N, Hara S, Ishimoto H, Nakashima S, Yura H, Miyamura T, Okuno D, Hara A, Kakugawa T, Yamaguchi H, Obase Y, Kushima H, Ishii H, Noguchi S, Kido T, Kobayashi T, Soejima Y, Yoshioka S, Ishimatsu Y, Yatera K, Kadota JI, Mukae H.

Tohoku J Exp Med. 2019 Jul;248(3):209-216. doi: 10.1620/tjem.248.209.

2.

Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study.

Miyamura T, Sakamoto N, Kakugawa T, Okuno D, Yura H, Nakashima S, Ishimoto H, Kido T, Taniguchi D, Miyazaki T, Tsuchiya T, Tsutsui S, Yamaguchi H, Obase Y, Ishimatsu Y, Ashizawa K, Nagayasu T, Mukae H.

Respir Res. 2019 Jul 15;20(1):154. doi: 10.1186/s12931-019-1128-5.

3.

Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.

Sakamoto N, Ishimoto H, Nakashima S, Yura H, Miyamura T, Okuno D, Hara A, Kitazaki T, Kakugawa T, Ishimatsu Y, Satoh M, Mukae H.

Intern Med. 2019 Mar 15;58(6):837-841. doi: 10.2169/internalmedicine.1516-18. Epub 2018 Nov 19.

4.

Pulmonary Alveolar Proteinosis with Ulcerative Colitis.

Sakamoto N, Nakashima S, Ishimoto H, Kakugawa T, Hara A, Yura H, Miyamura T, Nakamichi S, Obase Y, Ishimatsu Y, Mukae H.

Intern Med. 2018 Sep 15;57(18):2705-2708. doi: 10.2169/internalmedicine.0555-17. Epub 2018 Apr 27.

5.

Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren's syndrome.

Kakugawa T, Sakamoto N, Ishimoto H, Shimizu T, Nakamura H, Nawata A, Ito C, Sato S, Hanaka T, Oda K, Kido T, Miyamura T, Nakashima S, Aoki T, Nakamichi S, Obase Y, Saito K, Yatera K, Ishimatsu Y, Nakayama T, Korogi Y, Kawakami A, Tanaka Y, Mukae H.

Respir Med. 2018 Apr;137:95-102. doi: 10.1016/j.rmed.2018.02.023. Epub 2018 Mar 1.

PMID:
29605220
6.

Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease.

Sakamoto N, Ishimoto H, Kakugawa T, Satoh M, Hasegawa T, Tanaka S, Hara A, Nakashima S, Yura H, Miyamura T, Koyama H, Morita T, Nakamichi S, Obase Y, Ishimatsu Y, Mukae H.

BMC Pulm Med. 2018 Mar 12;18(1):44. doi: 10.1186/s12890-018-0609-5.

7.

Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.

Yura H, Sakamoto N, Satoh M, Ishimoto H, Hanaka T, Ito C, Hasegawa T, Tanaka S, Miyamura T, Nakashima S, Hara A, Kakugawa T, Oda K, Kido T, Obase Y, Ishimatsu Y, Yatera K, Kawakami A, Mukae H.

Respir Med. 2017 Nov;132:189-194. doi: 10.1016/j.rmed.2017.10.020. Epub 2017 Oct 28.

8.

The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report.

Taniguchi D, Yamasaki N, Miyazaki T, Tsuchiya T, Matsumoto K, Hatachi G, Kakugawa T, Sakamoto N, Mukae H, Nagayasu T.

Surg Today. 2017 Nov;47(11):1397-1404. doi: 10.1007/s00595-017-1551-5. Epub 2017 Jun 6.

PMID:
28589262
9.

Interstitial Lung Disease Induced by Pazopanib Treatment.

Ide S, Sakamoto N, Hara S, Hara A, Kakugawa T, Nakamura Y, Futsuki Y, Izumikawa K, Ishimatsu Y, Yanagihara K, Mukae H.

Intern Med. 2017;56(1):79-83. doi: 10.2169/internalmedicine.56.7380. Epub 2017 Jan 1.

10.

Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.

Harada T, Ishimatsu Y, Hara A, Morita T, Nakashima S, Kakugawa T, Sakamoto N, Kosai K, Izumikawa K, Yanagihara K, Mukae H, Kohno S.

J Pharmacol Exp Ther. 2016 Sep;358(3):457-63. doi: 10.1124/jpet.116.233932. Epub 2016 Jul 11.

PMID:
27489022
11.

Erratum to: Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies.

Tomonaga M, Sakamoto N, Ishimatsu Y, Kakugawa T, Harada T, Nakashima S, Hara A, Hara S, Horai Y, Kawakami A, Mukae H, Kohno S.

Lung. 2016 Oct;194(5):869. No abstract available.

PMID:
27448400
12.

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.

Kakugawa T, Sakamoto N, Sato S, Yura H, Harada T, Nakashima S, Hara A, Oda K, Ishimoto H, Yatera K, Ishimatsu Y, Obase Y, Kohno S, Mukae H.

Respir Res. 2016 Jul 11;17(1):79. doi: 10.1186/s12931-016-0400-1.

13.

Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease.

Hanada M, Sakamoto N, Ishimatsu Y, Kakugawa T, Obase Y, Kozu R, Senjyu H, Izumikawa K, Mukae H, Kohno S.

Respirology. 2016 Aug;21(6):1088-93. doi: 10.1111/resp.12807. Epub 2016 May 13.

14.

Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.

Sakamoto N, Kakugawa T, Hara A, Nakashima S, Yura H, Harada T, Ishimoto H, Yatera K, Kuwatsuka Y, Hara T, Ichinose K, Obase Y, Ishimatsu Y, Kohno S, Mukae H.

Respir Res. 2015 Dec 10;16:148. doi: 10.1186/s12931-015-0308-1.

15.

Utility of a Sputum Antigen Detection Test in Pneumococcal Pneumonia and Lower Respiratory Infectious Disease in Adults.

Fukushima K, Nakamura S, Inoue Y, Higashiyama Y, Ohmichi M, Ishida T, Yoshimura K, Sawai T, Takayanagi N, Nakahama C, Kakugawa T, Izumikawa K, Aoki N, Nishioka Y, Kosaka O, Kohno S.

Intern Med. 2015;54(22):2843-50. doi: 10.2169/internalmedicine.54.4082. Epub 2015 Nov 15.

16.

Identification of Helicobacter pylori VacA in human lung and its effects on lung cells.

Nakashima S, Kakugawa T, Yura H, Tomonaga M, Harada T, Hara A, Hara S, Nakano M, Yamasaki E, Sakamoto N, Ishimatsu Y, Isomoto H, Gochuico BR, Suffredini AF, Mukae H, Kurazono H, Hirayama T, Moss J, Kohno S.

Biochem Biophys Res Commun. 2015 May 8;460(3):721-726. doi: 10.1016/j.bbrc.2015.03.096. Epub 2015 Mar 25.

17.

Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia.

Sakamoto N, Ishimatsu Y, Kakugawa T, Yura H, Tomonaga M, Harada T, Nakashima S, Hara S, Hara A, Ishimoto H, Yatera K, Mukae H, Kohno S.

Respir Med. 2015 Feb;109(2):265-71. doi: 10.1016/j.rmed.2014.12.015. Epub 2015 Jan 7.

18.

An autopsy case of Hermansky-Pudlak syndrome: a case report and review of the literature on treatment.

Harada T, Ishimatsu Y, Nakashima S, Miura S, Tomonaga M, Kakugawa T, Hara S, Sakamoto N, Yoshii C, Mukae H, Kawabata Y, Kohno S.

Intern Med. 2014;53(23):2705-9. Epub 2014 Dec 1. Review.

19.

Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies.

Tomonaga M, Sakamoto N, Ishimatsu Y, Kakugawa T, Harada T, Nakashima S, Hara A, Hara S, Horai Y, Kawakami A, Mukae H, Kohno S.

Lung. 2015 Feb;193(1):79-83. doi: 10.1007/s00408-014-9665-7. Epub 2014 Nov 14. Erratum in: Lung. 2016 Oct;194(5):869.

PMID:
25394672
20.

A Japanese patient with Löfgren's syndrome with an HLA-DR12 allele and review of literature on Japanese patients.

Ishimatsu Y, Koyama H, Tomonaga M, Harada T, Nakashima S, Hara A, Hara S, Kakugawa T, Sakamoto N, Hayashi T, Kohno S.

Tohoku J Exp Med. 2014 Oct;234(2):137-41. Review.

21.

Bronchiolitis in a patient with ulcerative colitis treated with erythromycin.

Sakamoto N, Ishimatsu Y, Koyama H, Kakugawa T, Hara S, Tomonaga M, Harada T, Nakashima S, Mukae H, Kohno S.

Intern Med. 2014;53(8):875-7. Epub 2014 Apr 15.

22.

Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis.

Horai Y, Koga T, Fujikawa K, Takatani A, Nishino A, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Ida H, Kakugawa T, Sakamoto N, Ishimatsu Y, Mukae H, Hamaguchi Y, Fujimoto M, Kuwana M, Origuchi T, Kohno S, Kawakami A.

Mod Rheumatol. 2015 Jan;25(1):85-9. doi: 10.3109/14397595.2014.900843. Epub 2014 Apr 9.

PMID:
24716595
23.

Serum heat shock protein 47 levels are elevated in acute interstitial pneumonia.

Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Kubota H, Mine M, Matsuoka Y, Mukae H, Nagata K, Kohno S.

BMC Pulm Med. 2014 Mar 21;14:48. doi: 10.1186/1471-2466-14-48.

24.

Acute exacerbation of airspace enlargement with fibrosis.

Kakugawa T, Tabata K, Ogawara D, Tsuchiya T, Hara S, Sakamoto N, Ishimatsu Y, Ashizawa K, Nagayasu T, Fukuoka J, Kohno S.

Respir Med Case Rep. 2014 Aug 14;13:19-23. doi: 10.1016/j.rmcr.2014.07.005. eCollection 2014.

25.

Serum heat shock protein 47 levels in patients with drug-induced lung disease.

Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Matsuoka Y, Kubota H, Mine M, Mukae H, Nagata K, Kohno S.

Respir Res. 2013 Nov 20;14:133. doi: 10.1186/1465-9921-14-133.

26.

Interstitial pneumonia associated with linear immunoglobulin A/immunoglobulin G bullous dermatosis.

Kakugawa T, Tomimura S, Hayashi T, Sakamoto N, Ishimatsu Y, Mukae H, Kohno S.

Respiration. 2013;86(4):347-51. doi: 10.1159/000351427. Epub 2013 Sep 12.

27.

Diffuse alveolar hemorrhage in a patient with ankylosing spondylitis.

Hara S, Sakamoto N, Ishimatsu Y, Kakugawa T, Shimada M, Kohno S.

Intern Med. 2013;52(17):1963-6.

28.

Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis.

Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Kubota H, Mine M, Matsuoka Y, Mukae H, Nagata K, Kohno S.

Cell Stress Chaperones. 2013 Sep;18(5):581-90. doi: 10.1007/s12192-013-0411-5. Epub 2013 Feb 22.

29.

Development of imatinibmesylate-induced interstitial lung disease 2 weeks after discontinuation of the treatment: a case report.

Nakashima S, Kakugawa T, Motomura H, Hirano K, Sasaki E, Nagata Y, Kinoshita A, Sakamoto N, Ishimatsu Y, Mukae H, Kohno S.

Multidiscip Respir Med. 2012 Nov 23;7(1):48. doi: 10.1186/2049-6958-7-48.

30.

Elevated tenascin-C levels in bronchoalveolar lavage fluid of patients with sarcoidosis.

Fujita H, Sakamoto N, Ishimatsu Y, Kakugawa T, Nakashima S, Hara S, Hara A, Mukae H, Kohno S.

Lung. 2012 Oct;190(5):537-43. Epub 2012 Jul 4.

PMID:
22760918
31.

Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.

Hisatomi K, Mukae H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, Fujita H, Nakamichi S, Oku H, Urata Y, Kubota H, Nagata K, Kohno S.

BMC Pulm Med. 2012 Jun 13;12:24. doi: 10.1186/1471-2466-12-24.

32.

S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.

Hara A, Sakamoto N, Ishimatsu Y, Kakugawa T, Nakashima S, Hara S, Adachi M, Fujita H, Mukae H, Kohno S.

Respir Med. 2012 Apr;106(4):571-80. doi: 10.1016/j.rmed.2011.12.010. Epub 2011 Dec 30.

33.

A case of acute sarcoid myositis treated with weekly low-dose methotrexate.

Fujita H, Ishimatsu Y, Motomura M, Kakugawa T, Sakamoto N, Hayashi T, Kohno S.

Muscle Nerve. 2011 Dec;44(6):994-9. doi: 10.1002/mus.22222. Review.

PMID:
22102474
34.

Anti-inflammatory effects of garenoxacin on IL-8 production and ERK1/2 activation induced by lipopolysaccharides in A549 and THP-1 cells.

Hara S, Ishimatsu Y, Mukae H, Sakamoto N, Kakugawa T, Fujita H, Hara A, Kohno S.

Eur J Pharmacol. 2011 Oct 1;668(1-2):264-70. doi: 10.1016/j.ejphar.2011.06.046. Epub 2011 Jul 8.

PMID:
21762685
35.

Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis.

Fujita H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, Hara A, Amenomori M, Ishimoto H, Nagata T, Mukae H, Kohno S.

Respiration. 2011;81(5):420-30. doi: 10.1159/000324080. Epub 2011 Apr 19.

36.

A case of Sjögren syndrome with pulmonary amyloidosis complicating microscopic polyangiitis.

Kawashiri SY, Tamai M, Yamasaki S, Nakamura H, Kakugawa T, Sakamoto N, Ishimatsu Y, Kawakami A.

Mod Rheumatol. 2011 Dec;21(6):646-50. doi: 10.1007/s10165-011-0443-6. Epub 2011 Mar 25.

PMID:
21437616
37.

Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population.

Hara S, Henmi T, Kawakami A, Fujikawa K, Mukae H, Ishimatsu Y, Sakamoto N, Kakugawa T, Kaji K, Fujimoto M, Kuwana M, Tsukada T, Satoh K, Motomura M, Tamai M, Nakamura H, Ida H, Hayashi T, Origuchi T, Eguchi K, Kohno S.

Rheumatol Int. 2013 Apr;33(4):1059-64. doi: 10.1007/s00296-010-1662-4. Epub 2010 Dec 2.

PMID:
21125282
38.

Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study.

Hara S, Ishimoto H, Sakamoto N, Mukae H, Kakugawa T, Ishimatsu Y, Mine M, Kohno S.

Respiration. 2011;81(2):107-17. doi: 10.1159/000321958. Epub 2010 Dec 1.

39.

Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan.

Seki M, Hashiguchi K, Tanaka A, Kosai K, Kakugawa T, Awaya Y, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S.

J Infect Chemother. 2011 Jun;17(3):363-9. doi: 10.1007/s10156-010-0127-8. Epub 2010 Oct 8.

PMID:
20931256
40.

Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells.

Amenomori M, Mukae H, Ishimatsu Y, Sakamoto N, Kakugawa T, Hara A, Hara S, Fujita H, Ishimoto H, Hayashi T, Kohno S.

Exp Lung Res. 2010 Sep;36(7):411-9. doi: 10.3109/01902141003714049.

PMID:
20715983
41.

Sarcoidosis in a patient with systemic sclerosis and primary biliary cirrhosis.

Sakamoto N, Ishimatsu Y, Kakugawa T, Hara A, Hara S, Amenomori M, Fujita H, Mukae H, Kohno S.

Intern Med. 2010;49(15):1609-11. Epub 2010 Aug 2.

42.

Primary ciliary dyskinesia that responded to long-term, low-dose clarithromycin.

Yoshioka D, Sakamoto N, Ishimatsu Y, Kakugawa T, Ishii H, Mukae H, Kadota J, Kohno S.

Intern Med. 2010;49(14):1437-40. Epub 2010 Jul 15.

43.

Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis.

Migita K, Umeno T, Miyagawa K, Izumi Y, Sasaki E, Kakugawa T, Ito M, Kinoshita A, Miyashita T.

Rheumatol Int. 2012 May;32(5):1375-7. doi: 10.1007/s00296-010-1441-2. Epub 2010 Mar 27.

PMID:
20349068
44.

Drug-induced eosinophilic pneumonia with pulmonary alveolar hemorrhage caused by benzbromarone.

Hara A, Mukae H, Hara S, Amenomori M, Ishimoto H, Kakugawa T, Fujita H, Sakamoto N, Ishii H, Ishimatsu Y, Kohno S.

Intern Med. 2010;49(5):435-8. Epub 2010 Mar 1.

45.

HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia.

Amenomori M, Mukae H, Sakamoto N, Kakugawa T, Hayashi T, Hara A, Hara S, Fujita H, Ishimoto H, Ishimatsu Y, Nagayasu T, Kohno S.

Respir Med. 2010 Jun;104(6):895-901. doi: 10.1016/j.rmed.2010.01.011. Epub 2010 Feb 2.

46.

Localization of HSP47 mRNA in murine bleomycin-induced pulmonary fibrosis.

Kakugawa T, Mukae H, Hishikawa Y, Ishii H, Sakamoto N, Ishimatsu Y, Fujii T, Koji T, Kohno S.

Virchows Arch. 2010 Mar;456(3):309-15. doi: 10.1007/s00428-009-0876-x. Epub 2010 Jan 22.

PMID:
20094730
47.

[Myxoid type of malignant fibrous histiocytoma in the anterior mediastinum; report of a case].

Tamura S, Imadachi H, Kakugawa T, Toyama H, Kinoshita A, Matsuoka Y, Tsuji H, Ito M.

Kyobu Geka. 2009 Aug;62(9):847-9. Japanese.

PMID:
19670794
48.

Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.

Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, Ishimatsu Y, Kawakami A, Eguchi K, Kohno S.

Chest. 2009 Nov;136(5):1341-1347. doi: 10.1378/chest.08-2740. Epub 2009 Jul 6.

PMID:
19581351
49.

Lemierre's syndrome followed by acute respiratory distress syndrome successfully rescued by antibiotics and hemoperfusion with polymyxin B-immobilized fiber.

Takazono T, Izumikawa K, Tsurutani J, Tanaka A, Kakugawa T, Fukuda Y, Saito M, Kurihara S, Imamura Y, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S.

Jpn J Infect Dis. 2009 Mar;62(2):133-6.

50.

Evaluation of a rapid immunochromatographic ODK0501 assay for detecting Streptococcus pneumoniae antigen in sputum samples from patients with lower respiratory tract infection.

Izumikawa K, Akamatsu S, Kageyama A, Okada K, Kazuyama Y, Takayanagi N, Nakamura S, Inoue Y, Higashiyama Y, Fukushima K, Ishida T, Sawai T, Yoshimura K, Nakahama C, Ohmichi M, Kakugawa T, Nishioka Y, Aoki N, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S.

Clin Vaccine Immunol. 2009 May;16(5):672-8. doi: 10.1128/CVI.00308-08. Epub 2009 Mar 4. Erratum in: Clin Vaccine Immunol. 2011 Apr;18(4):695.

Supplemental Content

Loading ...
Support Center